NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 176 filers reported holding NEVRO CORP in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $223,000 | -35.7% | 5,100 | +6.2% | 0.00% | 0.0% |
| Q1 2022 | $347,000 | -10.8% | 4,800 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $389,000 | -30.3% | 4,800 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $558,000 | -31.3% | 4,800 | -2.0% | 0.00% | -33.3% |
| Q2 2021 | $812,000 | +66.4% | 4,900 | +40.0% | 0.00% | +50.0% |
| Q1 2021 | $488,000 | -65.6% | 3,500 | -57.3% | 0.00% | -60.0% |
| Q4 2020 | $1,419,000 | -12.9% | 8,200 | -29.9% | 0.01% | -28.6% |
| Q3 2020 | $1,629,000 | +12.7% | 11,700 | -3.3% | 0.01% | +16.7% |
| Q2 2020 | $1,445,000 | +21.5% | 12,100 | +1.7% | 0.01% | 0.0% |
| Q1 2020 | $1,189,000 | -19.7% | 11,900 | -5.6% | 0.01% | 0.0% |
| Q4 2019 | $1,481,000 | +153.6% | 12,600 | +85.3% | 0.01% | +500.0% |
| Q3 2019 | $584,000 | +30.1% | 6,800 | -1.9% | 0.00% | -50.0% |
| Q2 2019 | $449,000 | +3.7% | 6,929 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $433,000 | +61.0% | 6,929 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $269,000 | -31.7% | 6,929 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $394,000 | -36.1% | 6,929 | -10.4% | 0.00% | -33.3% |
| Q2 2018 | $617,000 | -7.8% | 7,729 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $669,000 | +40.0% | 7,729 | +11.5% | 0.00% | +50.0% |
| Q4 2017 | $478,000 | -36.8% | 6,929 | -16.8% | 0.00% | -33.3% |
| Q3 2017 | $756,000 | +2506.9% | 8,329 | +1982.2% | 0.00% | – |
| Q2 2017 | $29,000 | -71.8% | 400 | -63.6% | 0.00% | – |
| Q1 2017 | $103,000 | -75.5% | 1,100 | -81.0% | 0.00% | -100.0% |
| Q4 2016 | $421,000 | +75.4% | 5,795 | +152.0% | 0.00% | +100.0% |
| Q3 2016 | $240,000 | +990.9% | 2,300 | +666.7% | 0.00% | – |
| Q2 2016 | $22,000 | -95.9% | 300 | -96.9% | 0.00% | -100.0% |
| Q1 2016 | $542,000 | +24.9% | 9,666 | +50.3% | 0.00% | 0.0% |
| Q4 2015 | $434,000 | – | 6,433 | – | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2014 | $108,000 | – | 2,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |